LARGO, Fla. — A new type of pacemaker is on the market and now helping patients with heart issues in Florida. Danette Strange-Gay, the patient, hopes to be a kidney transplant recipient after years of ...

Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 hospitalizations and nearly 160,000 deaths in the United States each year. Globally, it is estimated ...

Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 hospitalizations and nearly 160,000 deaths in the United States each year. Globally, it is estimated ...

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

The human heart is a highly complex pump made of muscle, complete with its own electric power system, supplying the energy and oxygen it needs to function. The heart’s pumping action is regulated by ...

The FDA approved the Aveir DR dual-chamber leadless pacemaker, the first such device to make it to the market, manufacturer Abbott announced. Approved for the treatment of abnormal or slow heart ...

Single-chamber ventricular leadless pacemakers do not support atrial pacing or consistent atrioventricular synchrony. A dual-chamber leadless pacemaker system consisting of two devices implanted ...